<html>

<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<title>ANRF Past Grant Awards</title>
</head>

<body bgcolor="#FFFFFF" bgproperties="fixed">
<div align="center"><center>

<table border="0" cellspacing="0" width="640" style="margin-bottom: 0; padding-bottom: 0">
  <tr>
    <td width="12%"><p align="right"><a href="index.htm"><img src="IMAGES/ANR_logo-sm.gif"
    alt="Back to Home" border="0" width="80" height="83"></a></td>
    <td width="88%"><font color="#400080"><font face="Bookman Old Style" size="5">A</font><font
    size="4" face="Bookman Old Style">RTHRITIS </font><font face="Bookman Old Style" size="5">N</font><font
    size="4" face="Bookman Old Style">ATIONAL </font><font face="Bookman Old Style" size="5">R</font><font
    size="4" face="Bookman Old Style">ESEARCH </font><font face="Bookman Old Style" size="5">F</font><font
    size="4" face="Bookman Old Style">OUNDATION</font></font></td>
  </tr>
  <tr>
    <td width="100%" colspan="2"><font size="4" face="Bookman Old Style" color="#400080">Press
    Logo To Return to Main Menu</font></td>
  </tr>
</table>
</center></div>

<hr color="#FF0000" width="90%">
<div align="center"><center>

<table border="0" cellpadding="2" cellspacing="0" width="600">
  <tr>
    <td><font color="#FF0000"><big><b><u>Grant Awards Overview</u></b></big></font><p><strong><font
    size="3" color="#000000">The Arthritis National Research Foundation is proud to support
    young investigators studying the causes of arthritis. Their discoveries have led to the
    development of important new treatments to help those who spend each day in pain. The
    following table describes the grants awarded over the last five years.</font></strong></p>
    <p><strong><font size="3" color="#000000">&nbsp;</font></strong></td>
  </tr>
</table>
</center></div><div align="center"><center>

<table BORDER="1" CELLSPACING="1" CELLPADDING="7" WIDTH="600" bgcolor="#FFE6F4">
  <tr>
    <td WIDTH="80" VALIGN="top"><dir>
      <i><b><font FACE="Arial" SIZE="2"><p align="left"></font><font face="Arial" size="3"
      color="#400080">Date </font></b></i></p>
    </dir>
    </td>
    <td WIDTH="520" VALIGN="top"><dir>
      <i><b><font FACE="Arial" SIZE="2"><p></font><font face="Arial" size="3" color="#400080">Grants
      Awarded</font></b></i></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman"
    size="3">1998-99</font></strong></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Elizabeth Mellins, M.D., Stanford University
      Medical Center: </i>$40,000 to study the genetics of rheumatoid arthritis.<b> </b>Dr.
      Mellins is examining if inherited genetic alterations in the recognition mechanism of the
      immune system are defective and cause RA patients to identify certain self-antigens as
      foreign.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman"
    size="3">1998-99</font></strong></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Susan Kovats, Ph.D., Beckman Research Institute,
      City of Hope:</i> $35,000 to study the nature of self-antigens in rheumatoid<b> </b>arthritis.<b>
      </b>This study focuses on whether tissue damage or infection confuses the recognition
      mechanism of the immune system, causing attack on self-tissues.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman"
    size="3">1998-99</font></strong></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Paul Utz, M.D., Harvard Medical School:</i>
      $40,000 to study cell death&#146;s role in the development of autoimmune diseases.<b> </b>Dr.
      Utz is focusing<b> </b>on<b> </b>the mechanism of how proteins released from dying
      self-cells can be modified, then stimulate the patient&#146;s immune system.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman"
    size="3">1998-99</font></strong></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Rebecca Tuetken, M.D., Ph.D., University of Iowa:
      </i>$40,000 to study how the immune system recognizes and reacts against foreign and
      self-DNA. The study will provide insight to the innate immune response to bacterial DNA
      and the pathogenesis of SLE.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><strong><font face="Times New Roman" size="3">&nbsp;</font></strong><p
    ALIGN="CENTER"><strong><font face="Times New Roman" size="3">1997-98</font></strong></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Morteza Setareh, Ph.D., Scripps Research
      Institute</i>:<i> </i>$38,000 to study the molecular make-up of genes and the mechanism
      whereby an autoimmune response is triggered as in arthritis, lupus and other rheumatic
      diseases.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1997-98</strong></font></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Arunan Kaliyaperumal, Ph.D., Northwestern
      University</i>:<i> </i>$38,000 to study the etiologic mechanism of Systemic Lupus
      Erythematosus (Lupus) and design an autoantigen-specific therapy to block the autoimmune
      response in Lupus.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1997-98</strong></font></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Mariana Linker-Israeli, Ph.D., Cedars-Sinai
      Medical Center</i>: $38,000 for a project examining the cellular and molecular
      characteristics of patients with Lupus (SLE). By studying the susceptibility genes
      involved, Dr. Linker-Israeli hopes to devise screening methods and targeted regimens of
      therapy.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1994-95/</strong></font></p>
    <p ALIGN="CENTER"><font size="3"><strong>1996-97</strong></font></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Chaim Jacob, M.D., Ph.D., University of Southern
      California</i>: $50,000 for Systemic Lupus Erythematosus research utilizing new screening
      techniques to test Lupus genes for identifiable mutations, which could be targets for gene
      therapy in the future.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1996-97</strong></font></p>
    <p ALIGN="CENTER"><font size="3"><strong>&nbsp;</strong></font></p>
    <p ALIGN="CENTER"><font size="3"><strong>&nbsp;</strong></font></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Salvatore Albani, M.D., University of California,
      San Diego School of Medicine</i>: $50,000 to study abnormal immune responses specific to
      Pauciarticular Juvenile Rheumatoid Arthritis (pJRA). Provides new information about the
      cause of this disease and opens the possibility of prevention and new therapies.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1995-96</strong></font></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Onsi Kamel, M.D., Stanford University Medical
      Center</i>: $50,000 to study the propensity for patients with Rheumatoid Arthritis to
      develop lymphomas (cancer) as a result of immunosuppressive therapy used to treat the
      arthritis. Study to provide data to allow for more careful monitoring of such treatment,
      thereby preventing the development of such lymphomas.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman"
    size="3">1995-96</font></strong></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">William Stohl, M.D., Ph.D., University of
      Southern California Medical Center</i>: $50,000 to assess the nature of the body&#146;s
      inability to regulate antibody production in patients with Systemic Lupus Erythmatosus
      (SLE). With a better knowledge of these mechanisms, specific therapies may be developed to
      block autoantibody production and reduce (or eliminate) the manifestations of SLE.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman"
    size="3">1994-95</font></strong></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Tetsuya Gatanaga, Ph.D., University of
      California, Irvine: </i>$37,500 to study<i> Cytokines</i>, a class of molecules, one of
      which is termed TNF, may be involved in the tissue destruction seen in Rheumatoid
      Arthritis. Dr. Gatanaga&#146;s team has isolated a specific molecule that blocks <i>cytokine</i>
      activity.</font></p>
    </dir>
    </td>
  </tr>
  <tr>
    <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman"
    size="3">1993-94</font></strong></td>
    <td WIDTH="520" VALIGN="top"><i><dir>
      <p><font face="Times New Roman" size="3">Betty Tsao, Ph.D., University of California, Los
      Angeles</i>: $42,000 to develop Immunotherapy by Peptides in Murine Lupus. A study to
      isolate and utilize peptides derived from autoantibodies to alter production of
      autoantibodies in patients with SLE.</font></p>
    </dir>
    </td>
  </tr>
</table>
</center></div>

<p align="center"><a href="awards.htm"><font face="Times New Roman" size="3"
color="#400080"><strong>Back to Top</strong></font></a></p>

<hr color="#FF0000" width="90%">

<p align="center"><a href="about.htm">[Meet the ANRF]</a> <a href="whatis.htm">[Latest
Research]</a> <a href="giving.htm">[Support the Research]</a> <a href="donors.htm">[Our
Sponsors]</a><br>
<a href="grant.htm">[Grant Application Guidelines</a> <a href="cureart1.htm">[<em>Cure</em>Arthritis
Newsletter]</a> <a href="useful.htm">[Arthritis Info &amp; Links]</a> <a
href="contact.htm">[Contact Us]</a></p>

<p align="center"><b><font color="#0000FF">This page, and all the contents of this Web
site,<br>
are Copyright © 1999 by TouchVision,<br>
Seal Beach, California. All rights reserved.</font></b> <br>
<font size="2" face="ARIAL,HELVETICA"><b>Best experienced with<br>
<a href="http://www.microsoft.com/ie/ie.htm"><img src="ie_animated.gif"
alt="Microsoft Internet Explorer" border="0" vspace="7" width="88" height="31"></a> </b></font></p>
</body>
</html>
